Cardioproteomics: advancing the discovery of signaling mechanisms involved in cardiovascular diseases

被引:0
|
作者
Cui, Ziyou [1 ]
Dewey, Shannamar [1 ,2 ]
Gomes, Aldrin V. [1 ,3 ]
机构
[1] Univ Calif Davis, Dept Neurobiol Physiol & Behav, 176 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA
[2] Univ Calif Davis, Mol Cellular & Integrat Physiol Grad Program, Davis, CA 95616 USA
[3] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA
来源
关键词
Cardioproteomics; cardiovascular diseases; signaling pathway; proteomics; heart; mass spectrometry; drug signaling;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardioproteomics (Cardiovascular proteomics) is fast becoming an indispensible technique in deciphering changes in signaling pathways that occur in cardiovascular diseases (CVDs). The quality and availability of the instruments and bioinformatics software used for cardioproteomics continues to improve, and these techniques are now available to most cardiovascular researchers either directly or indirectly via university core centers. The heart and aorta are specialized tissues which present unique challenges to investigate. Currently, the diverse range of proteomic techniques available for cardiovascular research makes the choice of the best method or best combination of methods for the disease parameter(s) being investigated as important as the equipment used. This review focuses on proteomic techniques and their applications which have advanced our understanding of the signaling mechanisms involved in CVDs at the levels of protein complex/protein-protein interaction, post-translational modifications and signaling induced protein changes.
引用
收藏
页码:274 / 292
页数:19
相关论文
共 50 条
  • [1] Mechanisms involved in the association between peridontal diseases and cardiovascular disease
    Teles, R.
    Wang, C-Y
    ORAL DISEASES, 2011, 17 (05) : 450 - 461
  • [2] NOX signaling in molecular cardiovascular mechanisms involved in the blood pressure homeostasis
    Santillo, Mariarosaria
    Colantuoni, Antonio
    Mondola, Paolo
    Guida, Bruna
    Damiano, Simona
    FRONTIERS IN PHYSIOLOGY, 2015, 6
  • [3] TGFβ Signaling and Cardiovascular Diseases
    Pardali, Evangelia
    ten Dijke, Peter
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2012, 8 (02): : 195 - 213
  • [4] Matrix Metalloproteinases are Involved in Cardiovascular Diseases
    Azevedo, Aline
    Prado, Alejandro F.
    Antonio, Raquel C.
    Issa, Joao P.
    Gerlach, Raquel F.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 (04) : 301 - 314
  • [5] Matters of the Heart: Advancing Psychological Perspectives on Cardiovascular Diseases
    Matthews, Karen A.
    PERSPECTIVES ON PSYCHOLOGICAL SCIENCE, 2013, 8 (06) : 676 - 678
  • [6] Ferroptosis Mechanisms Involved in Neurodegenerative Diseases
    Reichert, Cadiele Oliana
    de Freitas, Fabio Alessandro
    Sampaio-Silva, Juliana
    Rokita-Rosa, Leonardo
    Barros, Priscila de Lima
    Levy, Debora
    Bydlowski, Sergio Paulo
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 27
  • [7] Decoding signaling mechanisms: unraveling the targets of guanylate cyclase agonists in cardiovascular and digestive diseases
    Yin, Qinan
    Zheng, Xingyue
    Song, Yujie
    Wu, Liuyun
    Li, Lian
    Tong, Rongsheng
    Han, Lizhu
    Bian, Yuan
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [8] Mechanisms of signaling involved in the resolution of inflammation
    Daniel Cervantes-Villagrana, Rodolfo
    Rafael Cervantes-Villagrana, Alberto
    Miguel Presno-Bernal, Jose
    GACETA MEDICA DE MEXICO, 2014, 150 (05): : 440 - 449
  • [9] Involvement of purinergic signaling in cardiovascular diseases
    Ralevic, V
    Burnstock, G
    DRUG NEWS & PERSPECTIVES, 2003, 16 (03) : 133 - 140
  • [10] Ceramide in Redox Signaling and Cardiovascular Diseases
    Li, Xiang
    Becker, Katrin Anne
    Zhang, Yang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2010, 26 (01) : 41 - 48